CCDR was launched in November 2012 and is dedicated to the late Professor Robert L. Sutherland AO FAA. Rob was a pioneer in translational research in Australia and internationally, and a visionary who adopted a ‘Bedside to Bench’ approach to cancer research.
As his daughter Rebecca Sutherland explains,
“Dad thought that by listening to patients and clinicians at the bedside, scientists could identify the most important research questions to answer at the bench. The importance of working to achieve this ideal was reinforced throughout Dad’s own cancer treatment. It is this bedside to bench approach that we continue through the organisation in a number of ways, so that in the end, patients receive the benefits of research, sooner”
CCDR continues to be guided by Rob’s ‘bedside to bench’ approach by listening to the needs of the community and conducting research to address their needs.